TM

Tejashkumar Maganbhai Patel

Active Director Director DIN 10760871
DIN 10760871 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Tejashkumar Maganbhai Patel

Data last updated:

Tejashkumar Maganbhai Patel is a Director at Mhdv Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10760871
Primary Designation Director
Industry Paper
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mhdv Pharmaceuticals Private Limited U21002GJ2024PTC154822
Director30 Aug 20242024Active

Board colleagues of Tejashkumar Maganbhai Patel

Directorship timeline

Open interactive timeline →
Mhdv Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tejashkumar Maganbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejashkumar Maganbhai Patel

Tejashkumar Maganbhai Patel currently holds 1 directorship: Mhdv Pharmaceuticals Private Limited (Director, since 30 Aug 2024).

Tejashkumar Maganbhai Patel was first appointed on 30 Aug 2024 as Director at Mhdv Pharmaceuticals Private Limited.

The current boards of Tejashkumar Maganbhai Patel's companies include Jayeshkumar Manharlal Bhavsar (Mhdv Pharmaceuticals Private Limited), Riteshkumar Madanlal Panjabi (Mhdv Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available